Florida Senate - 2016 COMMITTEE AMENDMENT Bill No. CS for SB 938 Ì526230nÎ526230 LEGISLATIVE ACTION Senate . House Comm: RCS . 02/16/2016 . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— The Committee on Commerce and Tourism (Bean) recommended the following: 1 Senate Amendment 2 3 Delete lines 53 - 66 4 and insert: 5 a finished drug product containing any quantity of 6 dextromethorphan in violation of this section is subject to a 7 written warning for an initial violation and, for each 8 subsequent violation, a civil citation imposing a fine of not 9 more than $100, which shall accrue and may be recovered in a 10 civil action brought by the local jurisdiction. A manufacturer, 11 distributor, or retailer who demonstrates a good faith effort to 12 comply with this section is not subject to citation. 13 (b) An employee or representative of a manufacturer, 14 distributor, or retailer who, during the course of the 15 employee’s or representative’s employment or association with 16 the manufacturer, distributor, or retailer, sells a finished 17 drug product containing any quantity of dextromethorphan in 18 violation of this section is subject to a written warning. 19 (c) A person who possesses or receives a finished drug 20 product containing any quantity of dextromethorphan in